Skip to main content

Renal Artery Stenosis: Diagnosis and Management

  • Chapter
  • First Online:
Cardio-Nephrology

Abstract

Renal artery stenosis (RAS) is commonly atherosclerotic in origin and its incidence increases with age. Decreased renal perfusion causes renal ischemia, which activates the renin–angiotensin–aldosterone system and increases a variety of inflammatory and pro-fibrotic cytokines. This results in the development of hypertension and a decline in renal function. Unfortunately, the finding of renal artery stenosis does not always imply the presence of renal ischemia. Several randomized controlled trials have not demonstrated a benefit of renal artery revascularization over medical treatment with anti-hypertensive and lipid-lowering medications in regards to either blood pressure control or renal outcomes. All these trials have been faulted for including low-risk subjects who would not be expected to benefit from revascularization. It is clear that the majority of patients with RAS can be treated with medical therapy alone. The question is how to identify those patients who would benefit from revascularization. High-risk patients include those with resistant hypertension, unexplained worsening renal function, asymmetric renal size, and recurrent episodes of flash pulmonary. Those individuals should be evaluated by non-invasive imaging techniques. If a greater than 70% stenosis is found, renal arteriography should be performed. It is important to recognize, however, that even if a greater than 70% stenosis is confirmed on arteriography, this does not necessarily indicate the presence of renal ischemia. Several newer methodologies including BOLD MRI, dynamic contrast enhanced MRI and renal frame count have, in small studies, been shown to correlate with the presence of renal ischemia. Unfortunately, whether such techniques will actually be able to identify those patients who will benefit from revascularization will have to await larger trials. Until then the clinician will need to use his/her best judgement in the treatment of this disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Peng M, Jiang XJ, Dong H, et al. Etiology of renal artery stenosis in 2047 patients: a single-center retrospective analysis during a 15-year period in China. J Hum Hypertens. 2016;30:124–8.

    Google Scholar 

  2. Anderson GH Jr, Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens. 1994;12:609–15.

    Article  PubMed  Google Scholar 

  3. Holley KE, Hunt JC, Brown AL Jr, Kincaid OW, Sheps SG. Renal artery stenosis. A clinical-pathologic study in normotensive and hypertensive patients. Am J Med. 1964;37:14–22.

    Article  CAS  PubMed  Google Scholar 

  4. Buller CE, Nogareda JG, Ramanathan K, et al. The profile of cardiac patients with renal artery stenosis. J Am Coll Cardiol. 2004;43:1606–13.

    Article  PubMed  Google Scholar 

  5. Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992;2:1608–16.

    CAS  PubMed  Google Scholar 

  6. Olin JW, Melia M, Young JR, Graor RA, Risius B. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med. 1990;88:46N–51N.

    Article  CAS  PubMed  Google Scholar 

  7. Zandparsa A, Habashizadeh M, Moradi Farsani E, Jabbari M, Rezaei R. Relationship between renal artery stenosis and severity of coronary artery disease in patients with coronary atherosclerotic disease. Int Cardiovasc Res J. 2012;6:84–7.

    PubMed  PubMed Central  Google Scholar 

  8. Burlacu A, Siriopol D, Voroneanu L, et al. Atherosclerotic renal artery stenosis prevalence and correlations in acute myocardial infarction patients undergoing primary percutaneous coronary interventions: data from nonrandomized single-center study (REN-ACS)—a single center, prospective, observational study. J Am Heart Assoc. 2015;4:e002379.

    Article  PubMed  PubMed Central  Google Scholar 

  9. van Ampting JM, Penne EL, Beek FJ, Koomans HA, Boer WH, Beutler JJ. Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis. Nephrol Dial Transplant. 2003;18:1147–51.

    Article  PubMed  Google Scholar 

  10. Detection, evaluation, and treatment of renovascular hypertension. Final report. Working group on renovascular hypertension. Arch Intern Med 1987;147:820–9.

    Google Scholar 

  11. Alhaddad IA, Blum S, Heller EN, et al. Renal artery stenosis in minority patients undergoing diagnostic cardiac catheterization: prevalence and risk factors. J Cardiovasc Pharmacol Ther. 2001;6:147–53.

    Article  CAS  PubMed  Google Scholar 

  12. Jazrawi A, Darda S, Burke P, et al. Is race a risk factor for the development of renal artery stenosis? Cardiol Res Pract. 2009;2009:817987.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kalra PA, Guo H, Gilbertson DT, et al. Atherosclerotic renovascular disease in the United States. Kidney Int. 2010;77:37–43.

    Article  CAS  PubMed  Google Scholar 

  14. Murphy TP, Soares G, Kim M. Increase in utilization of percutaneous renal artery interventions by medicare beneficiaries, 1996–2000. AJR Am J Roentgenol. 2004;183:561–8.

    Article  PubMed  Google Scholar 

  15. Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X. Fibromuscular dysplasia. Orphanet J Rare Dis. 2007;2:28.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Alibaz-Oner F, Direskeneli H. Update on Takayasu’s arteritis. Presse Med. 2015;44:e259–65.

    Article  PubMed  Google Scholar 

  17. Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG. Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore). 1985;64:89–99.

    Article  CAS  Google Scholar 

  18. Peng M, Jiang XJ, Dong H, et al. Etiology of renal artery stenosis in 2047 patients: a single-center retrospective analysis during a 15-year period in China. J Hum Hypertens. 2016;30:124–8.

    Article  CAS  PubMed  Google Scholar 

  19. Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129–34.

    Article  CAS  PubMed  Google Scholar 

  20. Goldblatt H, Lynch J, Hanzal RF, Summerville WW. Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med. 1934;59:347–79.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Martinez-Maldonado M. Pathophysiology of renovascular hypertension. Hypertension. 1991;17:707–19.

    Article  CAS  PubMed  Google Scholar 

  22. Eirin A, Gloviczki ML, Tang H, et al. Inflammatory and injury signals released from the post-stenotic human kidney. Eur Heart J. 2013;34:540–548a.

    Article  CAS  PubMed  Google Scholar 

  23. Eirin A, Gloviczki ML, Tang H, et al. Chronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin. Nephrol Dial Transplant. 2012;27:4153–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Saad A, Herrmann SM, Crane J, et al. Stent revascularization restores cortical blood flow and reverses tissue hypoxia in atherosclerotic renal artery stenosis but fails to reverse inflammatory pathways or glomerular filtration rate. Circ Cardiovasc Interv. 2013;6:428–35.

    Article  PubMed  Google Scholar 

  25. Mui KW, Sleeswijk M, van den Hout H, van Baal J, Navis G, Woittiez AJ. Incidental renal artery stenosis is an independent predictor of mortality in patients with peripheral vascular disease. J Am Soc Nephrol. 2006;17:2069–74.

    Article  PubMed  Google Scholar 

  26. Shafique S, Peixoto AJ. Renal artery stenosis and cardiovascular risk. J Clin Hypertens (Greenwich). 2007;9:201–8.

    Article  Google Scholar 

  27. Messerli FH, Bangalore S, Makani H, et al. Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering syndrome. Eur Heart J. 2011;32:2231–5.

    Article  PubMed  Google Scholar 

  28. Pickering TG, Herman L, Devereux RB, et al. Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation. Lancet. 1988;2:551–2.

    Article  CAS  PubMed  Google Scholar 

  29. Pelta A, Andersen UB, Just S, Baekgaard N. Flash pulmonary edema in patients with renal artery stenosis—the Pickering syndrome. Blood Press. 2011;20:15–9.

    Article  PubMed  Google Scholar 

  30. Messina LM, Zelenock GB, Yao KA, Stanley JC. Renal revascularization for recurrent pulmonary edema in patients with poorly controlled hypertension and renal insufficiency: a distinct subgroup of patients with arteriosclerotic renal artery occlusive disease. J Vasc Surg. 1992;15:73–80 (discussion-2).

    Article  CAS  PubMed  Google Scholar 

  31. Bax L, Woittiez AJ, Kouwenberg HJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009;150(840–8):W150–1.

    Google Scholar 

  32. Cooper CJ, Murphy TP, Cutlip DE, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370:13–22.

    Article  CAS  PubMed  Google Scholar 

  33. Investigators A, Wheatley K, Ives N, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953–62.

    Article  Google Scholar 

  34. Jenks S, Yeoh SE, Conway BR. Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis. Cochrane Database Syst Rev. 2014;12:CD002944.

    Google Scholar 

  35. Herrmann SM, Saad A, Textor SC. Management of atherosclerotic renovascular disease after Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL). Nephrol Dial Transplant. 2015;30:366–75.

    Article  PubMed  Google Scholar 

  36. Mohan IV, Bourke V. The management of renal artery stenosis: an alternative interpretation of ASTRAL and CORAL. Eur J Vasc Endovasc Surg. 2015;49:465–73.

    Article  CAS  PubMed  Google Scholar 

  37. White CJ. The “chicken little” of renal stent trials: the CORAL trial in perspective. JACC Cardiovasc Interv. 2014;7:111–3.

    Article  PubMed  Google Scholar 

  38. Murphy TP, Cooper CJ, Matsumoto AH, et al. Renal artery stent outcomes: effect of baseline blood pressure, stenosis severity, and translesion pressure gradient. J Am Coll Cardiol. 2015;66:2487–94.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Weinberg I, Keyes MJ, Giri J, et al. Blood pressure response to renal artery stenting in 901 patients from five prospective multicenter FDA-approved trials. Catheter Cardiovasc Interv. 2014;83:603–9.

    Article  PubMed  Google Scholar 

  40. Ritchie J, Green D, Chrysochou C, Chalmers N, Foley RN, Kalra PA. High-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization. Am J Kidney Dis. 2014;63:186–97.

    Article  PubMed  Google Scholar 

  41. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006;47:1239–312.

    Article  PubMed  Google Scholar 

  42. Parikh SA, Shishehbor MH, Gray BH, White CJ, Jaff MR. SCAI expert consensus statement for renal artery stenting appropriate use. Catheter Cardiovasc Interv. 2014;84:1163–71.

    Article  PubMed  Google Scholar 

  43. Ronden RA, Houben AJ, Kessels AG, Stehouwer CD, de Leeuw PW, Kroon AA. Predictors of clinical outcome after stent placement in atherosclerotic renal artery stenosis: a systematic review and meta-analysis of prospective studies. J Hypertens. 2010;28:2370–7.

    Article  CAS  PubMed  Google Scholar 

  44. Williams GJ, Macaskill P, Chan SF, et al. Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis. AJR Am J Roentgenol. 2007;188:798–811.

    Article  PubMed  Google Scholar 

  45. Olin JW, Piedmonte MR, Young JR, DeAnna S, Grubb M, Childs MB. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med. 1995;122:833–8.

    Article  CAS  PubMed  Google Scholar 

  46. Rountas C, Vlychou M, Vassiou K, et al. Imaging modalities for renal artery stenosis in suspected renovascular hypertension: prospective intraindividual comparison of color Doppler US, CT angiography, GD-enhanced MR angiography, and digital substraction angiography. Ren Fail. 2007;29:295–302.

    Article  CAS  PubMed  Google Scholar 

  47. Eklof H, Ahlstrom H, Magnusson A, et al. A prospective comparison of duplex ultrasonography, captopril renography, MRA, and CTA in assessing renal artery stenosis. Acta Radiol. 2006;47:764–74.

    Article  CAS  PubMed  Google Scholar 

  48. Eriksson P, Mohammed AA, De Geer J, et al. Non-invasive investigations of potential renal artery stenosis in renal insufficiency. Nephrol Dial Transplant. 2010;25:3607–14.

    Article  PubMed  Google Scholar 

  49. Albert TS, Akahane M, Parienty I, et al. An international multicenter comparison of time-SLIP unenhanced MR angiography and contrast-enhanced CT angiography for assessing renal artery stenosis: the renal artery contrast-free trial. AJR Am J Roentgenol. 2015;204:182–8.

    Article  PubMed  Google Scholar 

  50. Angeretti MG, Lumia D, Cani A, et al. Non-enhanced MR angiography of renal arteries: comparison with contrast-enhanced MR angiography. Acta Radiol. 2013;54:749–56.

    Article  CAS  PubMed  Google Scholar 

  51. Subramanian R, White CJ, Rosenfield K, et al. Renal fractional flow reserve: a hemodynamic evaluation of moderate renal artery stenoses. Catheter Cardiovasc Interv. 2005;64:480–6.

    Article  PubMed  Google Scholar 

  52. Textor SC, Lerman LO. Paradigm shifts in atherosclerotic renovascular disease: where are we now? J Am Soc Nephrol. 2015;26:2074–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Gloviczki ML, Glockner JF, Lerman LO, et al. Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Hypertension. 2010;55:961–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. De Bruyne B, Manoharan G, Pijls NH, et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol. 2006;48:1851–5.

    Article  PubMed  Google Scholar 

  55. Kadziela J, Januszewicz A, Prejbisz A, et al. Prognostic value of renal fractional flow reserve in blood pressure response after renal artery stenting (PREFER study). Cardiol J. 2013;20:418–22.

    Article  PubMed  Google Scholar 

  56. Kadziela J, Prejbisz A, Michalowska I, et al. Relationship between hemodynamic parameters of renal artery stenosis and the changes of kidney function after renal artery stenting in patients with hypertension and preserved renal function. Blood Press. 2015;24:30–4.

    Article  PubMed  Google Scholar 

  57. Naghi J, Palakodeti S, Ang L, Reeves R, Patel M, Mahmud E. Renal frame count: a measure of renal flow that predicts success of renal artery stenting in hypertensive patients. Catheter Cardiovasc Interv. 2015;86:304–9.

    Article  PubMed  Google Scholar 

  58. Lim SW, Chrysochou C, Buckley DL, Kalra PA, Sourbron SP. Prediction and assessment of responses to renal artery revascularization with dynamic contrast-enhanced magnetic resonance imaging: a pilot study. Am J Physiol Renal Physiol. 2013;305:F672–8.

    Article  CAS  PubMed  Google Scholar 

  59. Gloviczki ML, Saad A, Textor SC. Blood oxygen level-dependent (BOLD) MRI analysis in atherosclerotic renal artery stenosis. Curr Opin Nephrol Hypertens. 2013;22:519–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Harold M. Szerlip .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Szerlip, H.M., Singh, B. (2017). Renal Artery Stenosis: Diagnosis and Management. In: Rangaswami, J., Lerma, E., Ronco, C. (eds) Cardio-Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-319-56042-7_40

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56042-7_40

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56040-3

  • Online ISBN: 978-3-319-56042-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics